...
首页> 外文期刊>Case Reports in Hematology >Hypercalcemia in Small Lymphocytic Lymphoma with an Elevated Parathyroid Hormone-Related Peptide Associated with Early Richter Transformation
【24h】

Hypercalcemia in Small Lymphocytic Lymphoma with an Elevated Parathyroid Hormone-Related Peptide Associated with Early Richter Transformation

机译:小淋巴细胞淋巴瘤的高钙血症,其甲状旁腺激素相关肽的升高与早期RICHTER转换相关

获取原文

摘要

Hypercalcemia in malignancy is associated with multiple mechanisms and occurs in up to 20–30% of cancer patients. We report a case of small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) associated with hypercalcemia and an elevation in parathyroid hormone-related peptide (PTHrP) in the setting of a Richter transformation. Real-time reverse transcriptase PCR on lymph node biopsy specimens obtained before and after transformation showed an 8-fold increase in PTHrP mRNA levels and about 2-fold decrease in the levels of its cognate receptor PTHR1. The findings of this case suggest that parathyroid hormone-related peptide might be useful in monitoring a specific group of patients with SLL/CLL who develop hypercalcemia during the course of their disease and could suggest an autocrine-like mechanism involving PTHrP in Richter transformation.
机译:恶性肿瘤的高钙血症与多种机制相关,并且发生在癌症患者的高达20-30%的癌症中。 我们举报了与高钙血症相关的小淋巴细胞淋巴瘤/慢性淋巴细胞白血病(SLL / CLL)和甲状旁腺激素相关肽(PPTHP)的升高,在RICHTER转换的情况下。 在转化之前和之后获得的淋巴结活检标本的实时逆转录酶PCR显示出PTHRP mRNA水平的8倍,其同源受体PTHR1的水平降低约2倍。 这种情况的结果表明,甲状旁腺激素相关的肽可能有助于监测在疾病过程中产生高钙血症的SLL / CLL的特定患者,并且可以提出一种涉及普尔特转型的自治机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号